De Lisle Partners LLP Makes New $1.39 Million Investment in Nutrien Ltd. $NTR

De Lisle Partners LLP purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 22,000 shares of the company’s stock, valued at approximately $1,385,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Guggenheim Capital LLC lifted its stake in shares of Nutrien by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after purchasing an additional 145 shares during the period. Minot DeBlois Advisors LLC boosted its holdings in shares of Nutrien by 1.8% in the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after buying an additional 164 shares during the last quarter. Banque Cantonale Vaudoise grew its position in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after buying an additional 164 shares during the period. Gould Asset Management LLC CA grew its position in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after buying an additional 165 shares during the period. Finally, EverSource Wealth Advisors LLC increased its holdings in Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock valued at $61,000 after buying an additional 176 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of NYSE:NTR opened at $75.36 on Friday. The company has a market capitalization of $36.05 billion, a P/E ratio of 15.26, a P/E/G ratio of 0.75 and a beta of 0.61. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36. The firm’s 50 day simple moving average is $66.42 and its two-hundred day simple moving average is $70.42. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The firm had revenue of $10.81 billion during the quarter, compared to analysts’ expectations of $10.44 billion. Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the company earned $2.65 earnings per share. Research analysts expect that Nutrien Ltd. will post 4.95 EPS for the current fiscal year.

Nutrien Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Tuesday, September 29th. Nutrien’s dividend payout ratio is presently 44.53%.

Analysts Set New Price Targets

Several research firms have weighed in on NTR. Wall Street Zen downgraded shares of Nutrien from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Thursday, April 30th. BNP Paribas Exane raised Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 target price on the stock in a report on Tuesday, July 28th. Berenberg Bank set a $65.00 target price on Nutrien and gave the company a “hold” rating in a research report on Wednesday, June 10th. Finally, Morgan Stanley cut their price target on Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Seventeen investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Nutrien presently has an average rating of “Moderate Buy” and a consensus price target of $81.58.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.